Stock 4350 MEDICAL SYSTEM NETWORK CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medical System Network Co., Ltd.

Equities

4350

JP3920940008

Drug Retailers

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
582 JPY +0.52% Intraday chart for Medical System Network Co., Ltd. -2.35% -10.32%
02-19 Tranche Update on Medical System Network Co., Ltd.'s Equity Buyback Plan announced on February 16, 2024. CI
02-19 Medical System Network Co., Ltd.'s Equity Buyback announced on February 16, 2024, has closed with 950,000 shares, representing 3.15% for ¥555.75 million. CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15,981 13,064 21,588 16,508 12,071 16,923 - -
Enterprise Value (EV) 1 43,175 38,890 44,028 37,873 34,446 40,343 35,698 33,165
P/E ratio 34.5 x -14.6 x 9.82 x 6.89 x 7.49 x 10.7 x 7.87 x 6.51 x
Yield 1.9% 2.33% 1.4% 2.19% 3% 1.8% 2.07% 2.07%
Capitalization / Revenue 0.16 x 0.12 x 0.21 x 0.15 x 0.11 x 0.17 x 0.14 x 0.13 x
EV / Revenue 0.44 x 0.37 x 0.42 x 0.35 x 0.31 x 0.35 x 0.29 x 0.26 x
EV / EBITDA 10.3 x 8.38 x 6.85 x 5.65 x 5.63 x 5.77 x 4.82 x 4.04 x
EV / FCF -13.2 x 19.2 x 13.2 x 25.3 x 906 x 10.3 x 17.7 x 14.5 x
FCF Yield -7.56% 5.21% 7.6% 3.96% 0.11% 9.68% 5.64% 6.88%
Price to Book 1.48 x 1.39 x 1.92 x 1.24 x 0.84 x 1.28 x 1 x 0.88 x
Nbr of stocks (in thousands) 30,381 30,381 30,320 30,179 30,179 29,229 - -
Reference price 2 526.0 430.0 712.0 547.0 400.0 579.0 579.0 579.0
Announcement Date 5/8/19 5/8/20 5/7/21 5/6/22 5/9/23 5/10/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 98,232 105,241 104,257 106,685 109,551 115,361 122,200 128,000
EBITDA 1 4,199 4,643 6,424 6,707 6,120 6,995 7,400 8,200
EBIT 1 1,428 1,615 3,429 3,852 3,163 3,832 4,200 5,000
Operating Margin 1.45% 1.53% 3.29% 3.61% 2.89% 3.32% 3.44% 3.91%
Earnings before Tax (EBT) 1 1,422 22 3,967 4,012 3,019 3,451 3,800 4,600
Net income 1 462 -895 2,198 2,394 1,610 1,860 2,150 2,600
Net margin 0.47% -0.85% 2.11% 2.24% 1.47% 1.61% 1.76% 2.03%
EPS 2 15.25 -29.48 72.51 79.35 53.38 61.89 73.60 89.00
Free Cash Flow 1 -3,266 2,025 3,344 1,499 38 3,907 2,012 2,283
FCF margin -3.32% 1.92% 3.21% 1.41% 0.03% 3.39% 1.65% 1.78%
FCF Conversion (EBITDA) - 43.61% 52.05% 22.35% 0.62% 55.85% 27.19% 27.84%
FCF Conversion (Net income) - - 152.14% 62.61% 2.36% 210.05% 93.58% 87.81%
Dividend per Share 2 10.00 10.00 10.00 12.00 12.00 12.00 12.00 12.00
Announcement Date 5/8/19 5/8/20 5/7/21 5/6/22 5/9/23 5/10/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4
Net sales 1 52,216 51,045 26,255 52,169 27,699 26,817 26,299 27,041 53,340 28,538 27,673 27,656 28,805 56,461 29,714 29,186 29,610 30,550 60,160 31,480 30,560
EBITDA - - - - - - - - - - - - - - - - - - - - -
EBIT 1 796 1,355 1,195 1,862 1,201 789 348 751 1,099 1,245 819 451 1,261 1,712 1,357 763 565 1,175 1,740 1,545 915
Operating Margin 1.52% 2.65% 4.55% 3.57% 4.34% 2.94% 1.32% 2.78% 2.06% 4.36% 2.96% 1.63% 4.38% 3.03% 4.57% 2.61% 1.91% 3.85% 2.89% 4.91% 2.99%
Earnings before Tax (EBT) 790 1,219 - 2,236 1,244 - 385 - 1,165 1,238 - 407 - 1,705 1,349 - - - - - -
Net income 1 218 578 848 1,431 713 250 91 411 502 693 415 148 713 861 832 167 148 713 861 832 457
Net margin 0.42% 1.13% 3.23% 2.74% 2.57% 0.93% 0.35% 1.52% 0.94% 2.43% 1.5% 0.54% 2.48% 1.52% 2.8% 0.57% 0.5% 2.33% 1.43% 2.64% 1.5%
EPS 7.190 19.08 - 47.46 23.62 - 3.020 - 16.64 22.96 - 4.920 - 28.54 27.57 - - - - - -
Dividend per Share 5.000 5.000 - 5.000 - - - - 6.000 - - - - 6.000 - - - - - - -
Announcement Date 11/7/19 11/6/20 11/5/21 11/5/21 2/4/22 5/6/22 8/5/22 11/4/22 11/4/22 2/3/23 5/9/23 8/8/23 11/7/23 11/7/23 2/6/24 5/10/24 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 27,194 25,826 22,440 21,365 22,375 20,906 18,775 16,242
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.476 x 5.562 x 3.493 x 3.185 x 3.656 x 2.989 x 2.537 x 1.981 x
Free Cash Flow 1 -3,266 2,025 3,344 1,499 38 3,907 2,012 2,283
ROE (net income / shareholders' equity) 4.3% -8.9% 21.3% 19.6% 11.6% 12.6% 13.4% 14.4%
ROA (Net income/ Total Assets) 2.28% 2.3% 5.32% 6.77% 5.19% 5.69% 6.1% 7.1%
Assets 1 20,267 -38,840 41,355 35,355 30,992 32,671 35,246 36,620
Book Value Per Share 2 355.0 310.0 370.0 440.0 479.0 519.0 581.0 658.0
Cash Flow per Share 68.70 30.20 134.0 137.0 114.0 129.0 - -
Capex 1 6,106 2,207 1,861 2,620 4,935 3,818 2,000 2,000
Capex / Sales 6.22% 2.1% 1.79% 2.46% 4.5% 3.31% 1.64% 1.56%
Announcement Date 5/8/19 5/8/20 5/7/21 5/6/22 5/9/23 5/10/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Medical System Network Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
MEDICAL SYSTEM NETWORK CO., LTD. Stock Medical System Network Co., Ltd.
-10.32% 107M
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-37.60% 10.02B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-20.05% 7.1B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-12.54% 5.68B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-12.49% 4.88B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-3.21% 4.57B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+68.00% 4.38B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-4.97% 4.03B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-32.73% 2.63B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-18.90% 2.61B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 4350 Stock
  4. Financials Medical System Network Co., Ltd.